Internal Medicine · New York, NY
NPI
1871791665
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave, Medical Oncology Fellowship Office
New York, NY, 10065
Phone (212) 639-6788
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
617 services
Medicare patients, 2024
158
Average age 72
Drug cost, 2024
$5.3M
791 prescriptions
Company payments, 2025
$29K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Helena Yu was code 99214 (office e&m - established), 427 times for 123 patients. In total Helena Yu billed 617 services in 8 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-05-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 427 | 123 | $83.27 | $36K |
| 99215 Office E&M - Established | Office | 121 | 55 | $135.31 | $16K |
| 99205 Office E&M - New | Office | 24 | 24 | $162.17 | $3,892 |
By year: 2022 $61K for 634 services; 2023 $57K for 593 services; 2024 $60K for 617 services.
Medicare prescription drug claims, 2024
In 2024, the drug Helena Yu prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 241 prescriptions and refills. In total Helena Yu wrote 791 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 241 | 245 | 32 | $4.1M |
| Dexamethasone Generic | 51 | 54 | 30 | $1,043 |
| Mirtazapine Generic | 37 | 41 | 11 | $321 |
| Erlotinib Hcl Generic | 35 | 35 | Under 11 | $79K |
| Xarelto Rivaroxaban | 33 | 41 | Under 11 | $22K |
| Pantoprazole Sodium Generic | 33 | 51 | 11 | $281 |
| Ondansetron Odt Ondansetron | 27 | 27 | 19 | $224 |
| Tepmetko Tepotinib Hcl | 25 | 25 | Under 11 | $460K |
| Prednisone Generic | 22 | 24 | 11 | $114 |
| Olanzapine Generic | 20 | 22 | Under 11 | $149 |
| Eliquis Apixaban | 17 | 17 | Under 11 | $9,662 |
| Escitalopram Oxalate Generic | 16 | 18 | Under 11 | $140 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 14 | 14 | Under 11 | $34.04 |
| Fentanyl Generic | 13 | 14 | Under 11 | $1,786 |
Brand drugs: 366 claims; generic drugs: 425 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Helena Yu $29K ($29K in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $6,880.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 3 | $6,880 |
| Janssen Biotech, Inc. JNJ | 7 | $4,944 |
| Gilead Sciences, Inc. GILD | 1 | $4,580 |
| AstraZeneca UK Limited AZN | 2 | $3,100 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $2,468 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $2,100 |
| Rigel Pharmaceuticals, Inc. RIGL | 3 | $1,870 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $1,327 |
| Orion Corporation | 1 | $1,300 |
| Janssen Global Services, LLC JNJ | 1 | $220 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.